SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) today announced that Niv E. Caviar, Executive Vice President, Chief Business and Financial Officer, will present on Tuesday, March 4, at 9:00 am Eastern Time during the Susquehanna Financial Group Second Annual SIGnificant Options in Healthcare Conference. On Wednesday, March 5, at 1:00 pm, at the conference, Matthew Linnik, Ph.D., Executive Vice President and Chief Scientific Officer, will participate in a panel discussion entitled: “Lupus: Crossing the Finish Line, New Therapies for SLE.” The conference will take place at The W Hotel in New York City.
